Mast cell activation syndrome (MCAS) affects more than 15% of the U.S. population but evades most practitioners’ radar. Just five years ago, it wasn’t even on my radar, despite already having 20 years of experience as a clinician at that time. The more I dug (similar to leaky gut and post-COVID syndrome), the more I found my patients were suffering from this disorder.
Galina Roofener, AP, LAc Dipl. Ac., Dipl. CH
Galina Roofener is the president of the Florida State Oriental Medicine Association (FSOMA). She graduated from East West College of Natural Medicine and currently works at the Cleveland Clinic as an acupuncturist and Chinese herbalist.